25
Participants
Start Date
August 24, 2000
Primary Completion Date
June 20, 2002
Study Completion Date
June 24, 2002
Etanercept
Administered by subcutaneous injection twice a week
Placebo to Etanerceot
Administered by subcutaneous injection twice a week
Methotrexate
Administered orally or subcutaneously once a week at the same dose as prior to study entry
Lead Sponsor
Amgen
INDUSTRY